Zietse Michiel, van der Zeeuw Shannon L, Gebbink Anne-Sophie Klein, de Vries Annemarie C, Crombag Marie-Rose B S, van Leeuwen Roelof W F, Hoedemakers Maaike J
Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Appl Health Econ Health Policy. 2025 Mar;23(2):183-195. doi: 10.1007/s40258-024-00937-6. Epub 2024 Dec 19.
Rising healthcare costs challenge the financial sustainability of healthcare systems. Interventional pharmacoeconomics has emerged as a vital discipline to improve the cost-effective and sustainable use of drugs in clinical practice. However, current efforts are often fragmented, highlighting the need for an integrated hospital-wide approach. This study aimed to develop a scalable framework to systematically identify and implement cost-effective and sustainable drug use practices in hospitals.
This study was conducted at the Erasmus University Medical Centre in Rotterdam between December 2022 and July 2023. A novel '8-Step Efficiency Model' was designed to systematically identify and evaluate strategies for cost-effective and sustainable drug use. The process involved identifying high-expenditure drugs, systematically assessing these drugs using the Efficiency Model, and conducting a multi-disciplinary evaluation of the proposed cost-effectiveness strategies.
The study assessed 39 high-cost drugs, representing 57% of the Dutch national expensive drug expenditure in 2021. Initiatives for enhancing cost-effectiveness and sustainability were identified or developed for 27 out of the 39 assessed drugs (51% of the national drug expenditure in 2021). Case examples of infliximab (e.g., wastage prevention) and intravenous immunoglobulins (e.g., lean body weight dosing) illustrate practical applications of the framework, resulting in substantial cost savings and improved sustainability.
This study presents a systematic scalable model for enhancing the cost-effectiveness of high-expenditure drugs in hospital settings. This approach not only addresses financial sustainability but also promotes the quality of patient care and sustainable drug use. This model could serve as a generic blueprint for other institutions to identify and implement cost-effective and sustainable drug use strategies.
不断上涨的医疗保健成本对医疗保健系统的财务可持续性构成挑战。介入药物经济学已成为一门重要学科,旨在提高临床实践中药物的成本效益和可持续使用。然而,目前的努力往往分散,凸显了采用全院综合方法的必要性。本研究旨在开发一个可扩展的框架,以系统地识别和实施医院中具有成本效益和可持续性的药物使用实践。
本研究于2022年12月至2023年7月在鹿特丹的伊拉斯姆斯大学医学中心进行。设计了一种新颖的“8步效率模型”,以系统地识别和评估具有成本效益和可持续性的药物使用策略。该过程包括识别高支出药物,使用效率模型对这些药物进行系统评估,并对提议的成本效益策略进行多学科评估。
该研究评估了39种高成本药物,占2021年荷兰国家昂贵药物支出的57%。在评估的39种药物中,有27种(占2021年国家药物支出的51%)确定或制定了提高成本效益和可持续性的举措。英夫利昔单抗(如预防浪费)和静脉注射免疫球蛋白(如根据瘦体重给药)的案例说明了该框架的实际应用,从而实现了大幅成本节约并提高了可持续性。
本研究提出了一个系统的可扩展模型,用于提高医院环境中高支出药物的成本效益。这种方法不仅解决了财务可持续性问题,还促进了患者护理质量和药物的可持续使用。该模型可作为其他机构识别和实施具有成本效益和可持续性的药物使用策略的通用蓝图。